CVS vs ELV
CVS Health and Elevance Health, both Healthcare
CVS Health is the larger company at $125B against $84B. On trailing earnings ELV is the cheaper of the two at a P/E of 18.3 against 22.7, a gap that is only a bargain if the two are growing at similar rates. Over the past year ELV returned +33% against +19% for CVS. The RyuScore puts ELV ahead, 78 against 54 out of 100.
| Figure | CVS | ELV |
|---|---|---|
| Last close | $86.18 | $413 |
| Market cap | $125B | $84B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 22.7 | 18.3 |
| Dividend yield | 3.2% | n/a |
| 1-year return | +19% | +33% |
| 5-year return | +20% | +20% |
| RyuScoresector-relative, 1–10 | 54/100 | 78/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
CVS Health
Revenue of $106B in Q2 2026, net income $3.0B. Its largest reported line is Health Services, 42% of the disclosed total.
Elevance Health
Revenue of $50B in Q2 2026, net income $1.5B. Its largest reported line is Reportable, 89% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.